These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 20300977)
21. [Aberrant promoter hypermethylation of CHFR in nasopharyngeal carcinoma]. Huang T; Du C; Yu N; Xiao X; Zhou X; Wang S; Huang G; Zhang Z Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 25(16):746-50. PubMed ID: 22070084 [TBL] [Abstract][Full Text] [Related]
22. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578 [TBL] [Abstract][Full Text] [Related]
23. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926 [TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia. Honda T; Tamura G; Waki T; Kawata S; Nishizuka S; Motoyama T Br J Cancer; 2004 May; 90(10):2013-6. PubMed ID: 15138487 [TBL] [Abstract][Full Text] [Related]
26. [Promoter methylation and expression of Runx3 gene in gastric cancer]. Li LY; Li JK; Shen Y; Yu L; Zhang JH Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):379-82. PubMed ID: 18636364 [TBL] [Abstract][Full Text] [Related]
27. Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer. Wang N; Sui F; Ma J; Su X; Liu J; Yao D; Shi B; Hou P; Yang Q Arch Med Res; 2016 May; 47(4):285-92. PubMed ID: 27664488 [TBL] [Abstract][Full Text] [Related]
28. Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas. Soutto M; Peng D; Razvi M; Ruemmele P; Hartmann A; Roessner A; Schneider-Stock R; El-Rifai W Cancer; 2010 Sep; 116(17):4033-42. PubMed ID: 20564104 [TBL] [Abstract][Full Text] [Related]
29. Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment. Llorca-Cardeñosa MJ; Fleitas T; Ibarrola-Villava M; Peña-Chilet M; Mongort C; Martinez-Ciarpaglini C; Navarro L; Gambardella V; Castillo J; Roselló S; Navarro S; Ribas G; Cervantes A Oncotarget; 2016 Sep; 7(39):63424-63436. PubMed ID: 27566570 [TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray. So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612 [TBL] [Abstract][Full Text] [Related]
32. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia. Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660 [TBL] [Abstract][Full Text] [Related]
33. Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients. Zheng Y; Zhang Y; Huang X; Chen L Hepatogastroenterology; 2011; 58(112):2007-11. PubMed ID: 22234069 [TBL] [Abstract][Full Text] [Related]
34. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419 [TBL] [Abstract][Full Text] [Related]
35. Alternative efficacy-predicting markers for paclitaxel instead of CHFR in non-small-cell lung cancer. Takeshita M; Koga T; Takayama K; Yano T; Maehara Y; Nakanishi Y; Sueishi K Cancer Biol Ther; 2010 Nov; 10(9):933-41. PubMed ID: 20855974 [TBL] [Abstract][Full Text] [Related]
36. Lack of RUNX3 regulation in human gastric cancer. Friedrich MJ; Rad R; Langer R; Voland P; Hoefler H; Schmid RM; Prinz C; Gerhard M J Pathol; 2006 Oct; 210(2):141-6. PubMed ID: 16917803 [TBL] [Abstract][Full Text] [Related]
37. Methylation of gene CHFR promoter in acute leukemia cells. Gong H; Liu W; Zhou J; Xu H J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):240-2. PubMed ID: 16201259 [TBL] [Abstract][Full Text] [Related]
38. CHFR promoter hypermethylation and reduced CHFR mRNA expression in ovarian cancer. Gao Y; Lou G; Zhang GM; Sun XW; Ma YY; Yang YM; Liu G Int J Biol Markers; 2009; 24(2):83-9. PubMed ID: 19634111 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer. Zuo J; Xia J; Ju F; Yan J; Zhu A; Jin S; Shan T; Zhou H Mol Cells; 2013 Apr; 35(4):313-9. PubMed ID: 23549984 [TBL] [Abstract][Full Text] [Related]
40. Investigation of transcriptional gene silencing and mechanism induced by shRNAs targeted to RUNX3 in vitro. Feng XZ; He XS; Zhuang YZ; Luo Q; Jiang JH; Yang S; Tang XF; Liu JL; Chen T World J Gastroenterol; 2008 May; 14(19):3006-14. PubMed ID: 18494051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]